Amrutanjan Health Care Ltd (AMRUTANJAN) — FY26 Annual Report | 28 August 2026

Amrutanjan Health Care Ltd reported FY26 revenue of ₹50,255.27 crore, up 10% YoY, with PAT at ₹5,791.78 crore and dividend of [amount context mismatch] per share. The company achieved 70% automation in critical processes, expanded distribution to 44,000 new chemist outlets (targeting 100K by FY27), and increased digital transformation to 85% by FY26-end. CSR spending reached ₹1.29 crore, focusing on education, women's health, and animal welfare. Key growth drivers include 19% sales growth in Comfy and 10% in pain management, alongside 24.7% volume growth in the Body Ache segment. The company emphasized rural expansion, digital channels (E-Com, Q-Com), and new product launches like Comfy Slimfit XXL Night Pads and Relief Nasal Spray. Strategic initiatives include a new ₹150 crore sanitary napkin plant in Telangana (700 million annual capacity) and US market entry via Amazon US for 'Amrutanjan Relief'.